Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maryam Rezanejad"'
Autor:
Mohammad Mirzakhani, Zahra Moulana, Mousa Mohammadnia-Afrouzi, Hamed Mehdinezhad, Mohammad Jafari, Mehdi Shahbazi, Reza Ghadimi, Mostafa Ghasemzadeh, Mahmoud Sadeghi-Haddad-Zavareh, Mojgan Bagherzadeh, Mahdi Sepidarkish, Ali Shokuhi Rad, Mostafa Javanian, Masomeh Bayani, Maryam Rezanejad
Publikováno v:
Apmis
There is very little knowledge about the immune responses, particularly cellular immunity to coronavirus disease 2019 (COVID‐19). The main objective of this study was to evaluate the frequency of T helper (Th) cell subtypes, including Th1, Th17, an
Autor:
Zahra Moulana, Parviz Amri Maleh, Mohammad Mirzakhani, Mousa Mohammadnia-Afrouzi, Mojgan Bagherzadeh, Mostafa Javanian, Mehdi Shahbazi, Mahdi Sepidarkish, Soheil Ebrahimpour, Maryam Rezanejad, Zahra Ahmadnia, Hosein Ghorbani, Masomeh Bayani
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 41(4)
The most recently discovered interferon (IFN) family, type III IFNs or lambda IFNs (IFN-λs) are caused by viral infection and act in mucosal barriers, such as the respiratory tract. In this study, we assessed the serum levels of IFN-λs in new coron
Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients
Autor:
Maryam Rezanejad, Mousa Mohammadnia-Afrouzi, Mohammad Jafari, Mojgan Bagherzadeh, Zahra Moulana, Mahdi Sepidarkish, Mohammad Mirzakhani, Mehdi Shahbazi
Publikováno v:
Microbial Pathogenesis
Background During viral infection, inhibitory receptors play a key role in regulating CD8 T-cell activity. The objective of this research was to investigate programmed cell death protein 1 (PD-1), T-cell immunoglobulin and mucin domain-containing pro